A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Clinical trial NCT05137054 · RECRUITING
Trial details
- NCT number
- NCT05137054
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-17
- Primary completion
- 2028-03-25
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.